We found that TXNIP RNA levels were six times lower in melanoma as in healthy control samples (Fig. 2A), and also significantly downregulated in malignant (PM or MM) versus benign (BMN) lesions in the two microarray datasets analyzed (Fig. 2B,C; Supp. The gene discussed is TXNIP; the disease is melanoma.